Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials

BACKGROUND: We evaluated the time to progression (TTP) and survival outcomes of second-line therapy for metastatic colorectal cancer among adults aged 70 years and older compared with younger adults following progression on first-line clinical trials. METHODS: Associations between clinical and disea...

Descripción completa

Detalles Bibliográficos
Autores principales: McCleary, Nadine J, Harmsen, William S, Haakenstad, Ellana, Cleary, James M, Meyerhardt, Jeffrey A, Zalcberg, John, Adams, Richard, Grothey, Axel, Sobrero, Alberto F, Van Cutsem, Eric, Goldberg, Richard M, Peeters, Marc, Tabernero, Josep, Seymour, Matt, Saltz, Leonard B, Giantonio, Bruce J, Arnold, Dirk, Rothenberg, Mace L, Koopman, Miriam, Schmoll, Hans-Joachim, Pitot, Henry C, Hoff, Paulo M, Tebbutt, Niall, Masi, Gianluca, Souglakos, John, Bokemeyer, Carsten, Heinemann, Volker, Yoshino, Takayuki, Chibaudel, Benoist, deGramont, Aimery, Shi, Qian, Lichtman, Stuart M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935011/
https://www.ncbi.nlm.nih.gov/pubmed/35603849
http://dx.doi.org/10.1093/jncics/pkac014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935011/
https://www.ncbi.nlm.nih.gov/pubmed/35603849
http://dx.doi.org/10.1093/jncics/pkac014

Ejemplares similares